CD8A and Stroke: In conclusion, our findings shed new light on the pivotal role of CD8+ T cells in the white matter injury after cerebral ischemic stroke and we propose that IL‐2mAb may be an intriguing therapeutic strategy for long‐term neuroprotection against demyelination after stroke.